Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR

Journal of Cellular Biochemistry

Volumn 71, Issue 3, 1998, Pages 429-440

  Masuyama, Hisashi ^a   MacDonald, Paul N ^a  

^a S Louis Univ Hlth Sciences Center   (United States)

Author keywords

1,25 (OH)2D3; AF 2 domain; Proteasome; SUG 1; VDR

Indexed keywords

PROTEASOME; VITAMIN D RECEPTOR;

ARTICLE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REPORTER GENE; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATE; ANIMALS; CALCITRIOL; CARRIER PROTEINS; CLONING, MOLECULAR; CYCLOHEXIMIDE; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HALF-LIFE; LACTONES; LEUPEPTINS; LIGANDS; MICE; MULTIENZYME COMPLEXES; OSTEOSARCOMA; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CALCITRIOL; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032404015     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P     Document Type: Article

References (52)

1. Akiyama K, Yokota K, Kagawa S, Shimbara N, DeMartino GN, Slaughter CA, Noda C, Tanaka K (1995): cDNA cloning of a new putative ATPase subunit p45 of the human 26S proteasome, a homolog of yeast transcriptional factor Sug1. FEBS Lett 363:151-156.
2. 3. Mol Endocrinol 7:1307-1312.
3. Barettino D, Ruiz MV, Stunnenberg HG (1994): Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049.
4. Carter P (1987): Improved oligonucleotide-directed mutagenesis using M13 vectors. Methods Enzymol 154:382-403.
5. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG (1995): Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751.
6. Coux O, Tanaka K, Goldberg AL (1996): Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847.
7. Danielian PS, White R, Lees JA, Parker MG (1992): Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033.
8. Darwish H, DeLuca HF (1993): Vitamin D-regulated gene expression. Crit Rev Eukaryot Gene Expr 3:89-116.
9. Deng WP, Nickoloff JA (1992): Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal Biochem 200:81-88.
10. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL (1996): Mechanistic studies on the inactivation of the proteasome by lactacystin: A central role for clasto-lactacystin beta-lactone. J Biol Chem 271:7273-7276.
11. Durand B, Saunders M, Gaundon C, Roy B, Losson R, Chambon P (1994): Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activation domain and influence of the nature of the response element on AF-2 activity. EMBO J 13:5370-5382.
12. Evans RM (1988): The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
13. Fagan R, Flint KJ, Jones N (1994): Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 78:799-811.
14. Fraser RA, Rossignol M, Heard DJ, Egly J-M, Chambon P (1997): SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. J Biol Chem 272:7122-7126.
15. Freedman LP (1992): Anatomy of the steroid receptor zinc finger region. Endocr Rev 13:129-145.
16. Ghislain M, Udvardy A, Mann C (1993): S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase. Nature 366:358-362.
17. Gietz D, Jean AS, Woods RA, Schiestl RH (1991): An improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20:1425.
18. Hannon GJ, Demetrick D, Beach D (1993): Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391.
19. Hershko A, Ciechanover A (1992): The ubiquitin system for protein degradation. Annu Rev Biochem 61:761-807.
20. Hilt W, Wolf DH (1995): Proteasomes of the yeast S. cerevisiae: Genes, structure and functions. Mol Biol Rep 21: 3-10.
21. Hong H, Kohli K, Garabedian MJ, Stallcup MR (1997): GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid and vitamin D receptor. Mol Cell Biol 17:2735-2744.
22. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L (1996): Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177.
23. Hsieh J-C, Jurutka PW, Galligan MA, Terpening CM, Haussler CA, Samuels DS, Shimizu Y, Shimizu N, Haussler MR (1991): Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. Proc Natl Acad Sci U S A 88:9315-9319.
24. Jeffers M, Taylor GA, Weidner M, Omura S, vande Woude GF (1997): Degradation of the Met tyrosice kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol 17:799-808.
25. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD (1995): Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
26. Liu YY, Collins ED, Norman AW, Peleg S (1997): Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and. J Biol Chem 272:3336-3345.
27. MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR (1993): Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13:5907-5917.
28. MacDonald PN, Dowd DR, Haussler MR (1994): New insight into the structure and functions of the vitamin D receptor. Semin Nephrol 14:101-118.
29. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC, DeLisle RK (1995): The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 270:4748-4752.
30. Masuyama H, Jefcoat SC, MacDonald PN (1997): The N-terminal domain of transcription factor IIB is required for direct interaction with vitamin D receptor and participates in vitamin D-mediated transcription. Mol Endocrinol 11:218-228.
31. Masuyama H, Brownfield C, St-Arnaud R, MacDonald P (1997): Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11:1507-1517.
32. Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T, Tanaka K, Ichihara A (1992): Ornithinedecarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360:597-599.
33. Nakajima S, Hsieh J-C, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR (1994): The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8:159-172.
34. Onate SA, Tsai SY, Tsai M-J, O'Malley BW (1995): Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
35. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994): The ubiquitin-proteasome pathway is required for processing the NF-kB 1 precursor protein and the activation of NF-kB. Cell 78:773-786.
36. 3. J Biol Chem 270:10551-10558.
37. Renaud J-P, Rochel N, Ruff M, Virat V, Chambon P, Gronemeyer H, Moras D (1995): Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
38. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL (1994): Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
39. Rubin DM, Coux O, Wefes I, Hengartner C, Young RA, Goldberg AL, Finley D (1996): Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature 379:655-657.
40. Scheffner M, Werness BA, Huiberegste JM, Levine AJ, Howley PM (1990): The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
41. Shapiro DJ, Sharp PA, Wahli WW, Keller MJ (1988): A high-efficiency HeLa cell nuclear transcription extract. DNA 7:47-55.
42. Swaffield JC, Bromberg JF, Johnston ST (1992): Alterations in a yeast ptorein resembling HIV Tat-binding protein relieve requirement for an acidic activation domain in GAL4. Nature 357:698-700.
43. Swaffield JC, Melcher K, Johnston ST (1995): A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein. Nature 374:88-91.
44. Tanaka K (1995): Molecular biology of proteasomes. Mol Biol Rep 21:21-26.
45. Terpening CM, Haussler CA, Jurutka PW, Galligan MA, Komm BS, Haussler MR (1991): The vitamin D-responsive element in the rat bone gla protein is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3-mediated transcriptional activation. Mol Endocrinol 5:373-385.
46. Trier M, Staszewski LM, Bohmann D (1994): Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 78:787-798.
47. Tsai MJ, O'Malley BW (1994): Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486.
48. 3 analog KH1060. Proc Natl Acad Sci U S A 93:10685-10690.
49. vom Bauer E, Zechel C, Heery D, Heine MJS, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R (1996): Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15:110-124.
50. Weeda G, Rossignol M, Fraser RA, Winkler GS, Vermeulen W. van't Veer LJ, Ma L, Hoeijimakers JHJ, Egly J-M (1997): The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor. Nucleic Acids Res 25:2274-2283.
51. 3. J Nutr 125:1690S-1694S.
52. 3 results from ligand-induced stabilization. J Biol Chem 267:20082-20086